27th Jul 2007 11:20
Alliance Pharma PLC27 July 2007 For Immediate Release 27 July 2007 ALLIANCE PHARMA PLC ("Alliance" or "the Company") Grant of Options Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, announcesthe following award of options over the Company's ordinary shares. Name Position Number of options Exercise Time of Percentage awarded price vesting of issued per ordinary share share capital Richard Finance 500,000 8.25p 11 July 2010 0.31%Wright Director Tony Sales & 105,000 9.25p 2 May 2010 0.06%Booley Marketing Director Mark Medical 610,000 9.25p 2 May 2010 0.38%Tomlinson Director Tony Booley has a total of 594,250 share options and an interest in 6,710,723Ordinary Shares of the Company. For further information: Alliance Pharma plc + 44 (0) 1249 466966John Dawson, Chief ExecutiveRichard Wright, Finance Directorwww.alliancepharma.co.uk Numis Securities + 44 (0) 20 7260 1000David PoutneyMichael Meade Buchanan Communications + 44 (0) 20 7466 5000Mark Court/Rebecca Skye Dietrich Notes to editors About Alliance Pharma Alliance Pharma, founded in 1996, is an AIM listed speciality pharmaceuticalcompany based in Chippenham, Wiltshire, UK. The company has a strong trackrecord of acquiring the rights to established niche brands and owns, or shares,the rights to 34 branded pharmaceutical products. Alliance Pharma's products are prescribed in the treatment of a wide range ofconditions and include brands used in periodontitis (a serious gum disease), theprevention of heart disease, in Parkinson's disease, in nutrition, in nasalinfections, in the treatment of dermatological conditions and in childbirth.Alliance Pharma's sales are mainly prescription driven. Its products aredistributed to hospitals directly and to pharmaceutical wholesalers whichservice both hospital and retail pharmacies with their prescriptionrequirements. Alliance Pharma joined the AIM market of the London Stock Exchange in December2003 and trades under the symbol APH. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Alliance Pharma